Is a Preventive Mastectomy the Right Choice For You?

0

Does having cancer in one breast increase the risk of cancer occurring in the other, healthy breast?

Young women with breast cancer often respond with a “yes” and overestimate the need to have the healthy breast surgically removed, according to a recent study by Dana-Farber investigators. However, the actual risk of cancer occurring in the healthy breast of those women without a genetic predisposition to breast cancer is only two to four percent.

Dr. Ann Partridge

Ann Partridge, MD, MPH, of the Susan F. Smith Center for Women’s Cancers at Dana-Farber

Ann Partridge, MD, MPH, the study’s senior author and director of the Institute’s Program for Young Women with Breast Cancer, and Shoshana Rosenberg, ScD, MPH, lead author, both of the Susan F. Smith Center for Women’s Cancers at Dana-Farber, found a disconnect between what many patients know – that undergoing a contralateral prophylactic mastectomy, or CPM, to remove a healthy breast has little impact on survival rates for most women – and the choices they make after receiving the anxiety-inducing diagnosis of breast cancer.

Watch as Partridge explains the study’s results, and the pros and cons of CPM:

Comments Sort By Newest

Leave a Reply

Your email address will not be published. Required fields are marked *

Blue Captcha Image
Refresh

*

Latest Tweets

Dana-Farber @danafarber
Coping with a Pediatric Brain Tumor Diagnosis: Tips for Families: https://t.co/giNwTXrIZ8 #pedcsm https://t.co/kTLso9bCsv
Dana-Farber @danafarber
Investigational drug abemaciclib shows promising activity against several cancer types. https://t.co/RZ0eiQn1cb https://t.co/u1A4y3zQw0

Make An Appointment

For adults: 877-442-3324

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.